Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kyowa Kirin Co's Total Liabilities for the quarter that ended in Dec. 2025 was 円214,528 Mil.
Kyowa Kirin Co's quarterly Total Liabilities
increased
from Jun. 2025 (円224,530.00 Mil) to Sep. 2025 (円231,324.00 Mil) but then
declined
from Sep. 2025 (円231,324.00 Mil) to Dec. 2025 (円214,528.00 Mil).
Kyowa Kirin Co's annual Total Liabilities
increased
from Dec. 2023 (円189,524.00 Mil) to Dec. 2024 (円216,552.00 Mil) but then
declined
from Dec. 2024 (円216,552.00 Mil) to Dec. 2025 (円214,528.00 Mil).
The historical data trend for Kyowa Kirin Co's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Kyowa Kirin Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of 円214,528 Mil mean?
Kyowa Kirin Co (TSE:4151) has a Total Liabilities of 円214,528 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Total Liabilities too high?
Kyowa Kirin Co's current Total Liabilities is 円214,528 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Total Liabilities compare to ZTS?
Kyowa Kirin Co's Total Liabilities of 円214,528 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Total Liabilities is 円214,528 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (TSE:4151) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,986.42, compared to a current price of 円2,554.50 — trading 14.5% below its estimated fair value. The current Total Liabilities is 円214,528 Mil. Kyowa Kirin Co's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kyowa Kirin Co (TSE:4151), the current Total Liabilities is 円214,528 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kyowa Kirin Co (TSE:4151) Overvalued in 2026?
Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued.
The current stock price of 円2,554.50 is trading 14.5% below its estimated GF Value™ of 円2,986.42.
GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.
Key valuation signals for TSE:4151:
Total Liabilities: 円214,528 Mil
GF Value™: 円2,986.42 vs. price of 円2,554.50 (14.5% below fair value)
No single metric tells the full story. See the TSE:4151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
90GF Score
Get the complete analysis for TSE:4151
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4151 has been successfully added to your 
